Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru
Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
The new facility marks Align’s first manufacturing presence in India and its fourth globally
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Revenue from operations climbed 13% to Rs. 886.87 crore
Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels
Subscribe To Our Newsletter & Stay Updated
